Workflow
北方华创(002371):薄膜沉积收入高增,进军离子注入强化平台能力

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a revenue of 8.2 billion yuan in Q1 2025, representing a year-on-year increase of 38% and a quarter-on-quarter decrease of 13%. The net profit attributable to the parent company was 1.6 billion yuan, up 39% year-on-year and up 36% quarter-on-quarter [4] - In 2024, the company is projected to achieve a revenue of 29.8 billion yuan, a year-on-year increase of 35%, with a net profit of 5.6 billion yuan, reflecting a 44% year-on-year increase [4] - The company has entered the ion implantation equipment market, launching its first ion implanter, Sirius MC 313, which enhances its competitiveness in the semiconductor manufacturing equipment sector [6] Financial Performance Summary - The company’s electronic process equipment revenue in 2024 is expected to reach 27.7 billion yuan, a year-on-year growth of 41%. This includes over 8 billion yuan from etching equipment (up approximately 33%), over 10 billion yuan from thin film deposition equipment (up approximately 67%), over 2 billion yuan from thermal processing equipment, and over 1 billion yuan from wet processing equipment [5] - The projected net profits for 2025-2027 are 7.71 billion, 9.42 billion, and 11.73 billion yuan, respectively, with corresponding EPS of 14.44, 17.63, and 21.96 yuan [7] - The company’s revenue is expected to grow at a compound annual growth rate (CAGR) of 33.1% from 2025 to 2026, with a net profit growth rate of 37.2% during the same period [8]